1-(3-Bromoprop-1-yn-1-yl)-4-fluorobenzene, 95%, 250mg

3-Metoxi-3-metil-1-butanol, mínimo 99 %, para síntesis, 2,5 L, envase de vidrio

N,N,N',N'-Tetraphenyl-1,4-phenylenediamine>98.0%(GC)5g

tert-Butyl hexahydro-1H-pyrrolo[3,4-c]pyridine-5(6H)-carboxylate hydrochloride, 95.0%, 5g

6-Chloro-3-(trifluoromethyl)pyridine-2-carboxylic acid, 97.0%, 10g

2,5-Dioxopyrrolidin-1-yl 6-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)hexanoate, 95+%, 1g

ethyl 2-amino-4-phenyl-1,3-thiazole-5-carboxylate, 95.0%, 1g

1-IODO-7-METHOXYISOQUINOLINE, 95.0%, 100mg

tert-Butyl 5-bromovalerate, 98.0%, 100g

2-(2-Pyridin-4-yl-ethylamino)-ethanol, 1g

tert-Butyl 4-(4-aminobenzyl)piperidine-1-carboxylate, 95.0%, 100mg

4-Formyl-2-methylthiazole, 95.0%, 1g

Ethyl 2-[(2-methoxy-2-oxoethyl)sulfanyl]acetate, 99.0%, 1g